Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
Clinical trial NCT04293887 · UNKNOWN
Trial details
- NCT number
- NCT04293887
- Sponsor
- Tongji Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2020-05-30
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.